Related Experiment Videos
Plasminogen activator inhibitor in acute stroke.
M J Brockmann1, G Schwendemann, T W Stief
1Department of Neurology, University of Essen, Germany.
Molecular and Chemical Neuropathology
|April 1, 1991
Summary
Elevated plasminogen activator inhibitor activity was observed in patients with acute ischemic stroke and transient ischemic attack (TIA). This finding suggests a potential role for plasminogen activator inhibitor in stroke development.
Area of Science:
- Neurology
- Cardiovascular Biology
- Biochemistry
Background:
- Ischemic stroke and transient ischemic attack (TIA) are significant health concerns.
- Plasminogen activator inhibitor (PAI) plays a role in the fibrinolytic system.
Purpose of the Study:
- To investigate plasminogen activator inhibitor activity levels in patients with acute ischemic stroke and TIA.
- To explore the correlation between PAI activity, serum triglycerides, and cerebrovascular events.
Main Methods:
- Plasma PAI activity was measured in patients with ischemic stroke/TIA and age-matched controls.
- Serum triglyceride levels were assessed.
- Statistical analysis was performed to compare groups and identify correlations.
Main Results:
- Patients with acute ischemic stroke exhibited significantly higher plasma PAI activity compared to controls.
- A positive correlation was found between serum triglycerides and PAI activity in both stroke patients and controls.
- PAI activity was significantly elevated in the stroke group (p < 0.003).
Conclusions:
- Plasminogen activator inhibitor activity may be implicated in the pathophysiology of ischemic stroke.
- The correlation between triglycerides and PAI activity warrants further investigation in cerebrovascular disease.